Harbor Investment Advisory’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,240
Closed -$22.4K 1157
2024
Q2
$22.4K Hold
2,240
﹤0.01% 724
2024
Q1
$25.8K Hold
2,240
﹤0.01% 698
2023
Q4
$16.3K Hold
2,240
﹤0.01% 749
2023
Q3
$20.4K Hold
2,240
﹤0.01% 692
2023
Q2
$27.3K Hold
2,240
﹤0.01% 844
2023
Q1
$27.8K Hold
2,240
﹤0.01% 843
2022
Q4
$43.1K Hold
2,240
0.01% 725
2022
Q3
$42K Hold
2,240
0.01% 740
2022
Q2
$40K Hold
2,240
0.01% 758
2022
Q1
$36K Hold
2,240
﹤0.01% 815
2021
Q4
$55K Hold
2,240
0.01% 710
2021
Q3
$52K Hold
2,240
0.01% 729
2021
Q2
$61K Buy
2,240
+500
+29% +$14.3K 0.01% 647
2021
Q1
$64K Hold
1,740
0.01% 607
2020
Q4
$65K Hold
1,740
0.01% 561
2020
Q3
$38K Hold
1,740
0.01% 578
2020
Q2
$28K Hold
1,740
0.01% 554
2020
Q1
$28K Buy
+1,740
New +$24.6K 0.01% 505

Other funds holding AHCO

Harbor Investment Advisory's AHCO Position: Q3 2024 in Review

Harbor Investment Advisory sold out of AdaptHealth (AHCO) in Q3 2024, closing a stake of 2,240 shares — an estimated $22.4K sold.

Harbor Investment Advisory first reported a position in AHCO in Q1 2020 and held it in 18 quarters. The position peaked at $65K in Q4 2020. 217 funds tracked by Wall St. Rank hold AHCO as of Q3 2024.

  • Harbor Investment Advisory reported no remaining AdaptHealth position as of Q3 2024 after selling out during the quarter.
  • Harbor Investment Advisory sold 2,240 AdaptHealth shares in Q3 2024, an estimated $22.4K.
  • Harbor Investment Advisory first reported a position in AdaptHealth in Q1 2020 and held it in 18 quarters.
  • Harbor Investment Advisory's AdaptHealth position peaked at $65K in Q4 2020.
  • 217 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2024.

Based on Harbor Investment Advisory's 13F filing for Q3 2024, filed 4 Oct 2024.